Zobrazeno 1 - 10
of 87
pro vyhledávání: '"Benjamin W. Fischer‐Valuck"'
Autor:
Benjamin W. Fischer-Valuck, Brian C. Baumann, Simon A. Brown, Christopher P. Filson, Aaron Weiss, Ryan Mueller, Yuan Liu, Randall J. Brenneman, Martin Sanda, Jeff M. Michalski, Hiram A. Gay, Yuan James Rao, John G. Pattaras, Ashesh B. Jani, Bruce Hershatter, Sagar A. Patel
Publikováno v:
European Urology Open Science, Vol 37, Iss , Pp 80-89 (2022)
Background: Elderly patients diagnosed with high-risk prostate cancer (PCa) present a therapeutic dilemma of balancing treatment of a potentially lethal malignancy with overtreatment of a cancer that may not threaten life expectancy. Objective: To in
Externí odkaz:
https://doaj.org/article/bed16021cbda402da7800649e253f019
Autor:
Neal S. McCall, MD, Yuan Liu, PhD, Sagar A. Patel, MD, Bruce Hershatter, MD, Drew Moghanaki, MD, Karen D. Godette, MD, Sheela Hanasoge, MD, PhD, Pretesh Patel, MD, Benjamin W. Fischer-Valuck, MD, Joseph W. Shelton, MD, Ashesh B. Jani, MD
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 6, Pp 100803- (2021)
Purpose: Treatment with long-term androgen deprivation therapy (ADT) and radiation therapy (RT) is the nonsurgical standard-of-care for patients with high- or very high-risk prostate cancer (HR-PC), but the optimal timing between ADT and RT initiatio
Externí odkaz:
https://doaj.org/article/510c544551994ec9be4490c754652515
Autor:
Benjamin W. Fischer‐Valuck, Jeff M. Michalski, Nandita Mitra, John P. Christodouleas, Todd A. DeWees, Eric Kim, Zachary L. Smith, Gerald L. Andriole, Vivek Arora, Arnold Bullock, Ruben Carmona, Robert S. Figenshau, Robert L. Grubb, Thomas J. Guzzo, Eric M. Knoche, S. Bruce Malkowicz, Ronac Mamtani, Russell K. Pachynski, Bruce J. Roth, Mohamed S. Zaghloul, Hiram A. Gay, Brian C. Baumann
Publikováno v:
Cancer Medicine, Vol 8, Iss 8, Pp 3698-3709 (2019)
Abstract Background Local‐regional failure (LF) for locally advanced bladder cancer (LABC) after radical cystectomy (RC) is common even with chemotherapy and is associated with high morbidity/mortality. Postoperative radiotherapy (PORT) can reduce
Externí odkaz:
https://doaj.org/article/7476407db02e464298e90497e8635fe0
Autor:
Benjamin W. Fischer-Valuck, Jeff M. Michalski, Jessika A. Contreras, Randall Brenneman, John P. Christodouleas, Christopher D. Abraham, Eric H. Kim, Vivek K. Arora, Arnold D. Bullock, Ruben Carmona, Robert S. Figenshau, Robert Grubb, III, Eric M. Knoche, Russell K. Pachynski, Joel Picus, Bruce J. Roth, Paul Sargos, Gerald L. Andriole, Hiram A. Gay, Brian C. Baumann
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 15, Iss , Pp 38-41 (2019)
Introduction: Squamous cell carcinoma (SqCC) is the second most common histology of primary bladder cancer, but still very limited information is known about its treatment outcomes. Most bladder cancer trials have excluded SqCC, and the current treat
Externí odkaz:
https://doaj.org/article/d651c57419134a0cb6af5d407b8deb97
Autor:
Benjamin W. Fischer‐Valuck, Brian C. Baumann, Anthony Apicelli, Yuan James Rao, Michael Roach, Mackenzie Daly, Maria C. Dans, Patrick White, Jessika Contreras, Lauren Henke, Hiram Gay, Jeff M. Michalski, Christopher Abraham
Publikováno v:
Cancer Medicine, Vol 7, Iss 9, Pp 4240-4250 (2018)
Abstract Prostate cancer (PCa) is one of the most common malignancies associated with bone metastases, and palliative radiation therapy (RT) is an effective treatment option. A total of 2641 patients were identified with PCa and bone metastases at di
Externí odkaz:
https://doaj.org/article/5966954b0dbf4d42897656f4d02fa5d2
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
For patients with unfavorable or high-risk prostate cancer, dose escalated radiation therapy leads to improved progression free survival but attempts to deliver increased dose by external beam radiation therapy (EBRT) alone can be limited by late tox
Externí odkaz:
https://doaj.org/article/6783136de3f34494b513917e6a0fc671
Autor:
Benjamin W. Fischer-Valuck, MD, Lauren Henke, MD, Olga Green, PhD, Rojano Kashani, PhD, Sahaja Acharya, MD, Jeffrey D. Bradley, MD, Clifford G. Robinson, MD, Maria Thomas, MD, PhD, Imran Zoberi, MD, Wade Thorstad, MD, Hiram Gay, MD, Jiayi Huang, MD, Michael Roach, MD, Vivian Rodriguez, PhD, Lakshmi Santanam, PhD, Harold Li, PhD, Hua Li, PhD, Jessika Contreras, MD, Thomas Mazur, PhD, Dennis Hallahan, MD, Jeffrey R. Olsen, MD, Parag Parikh, MD, Sasa Mutic, PhD, Jeff Michalski, MD, MBA
Publikováno v:
Advances in Radiation Oncology, Vol 2, Iss 3, Pp 485-493 (2017)
Purpose: Magnetic resonance image guided radiation therapy (MR-IGRT) has been used at our institution since 2014. We report on more than 2 years of clinical experience in treating patients with the world's first MR-IGRT system. Methods and materials:
Externí odkaz:
https://doaj.org/article/97791972c9cd4c1bb3ad4531c7e89e97
Autor:
Sagar A. Patel, Brian Baumann, Jeff Michalski, Randall Brenneman, Bill Zheng, Hiram Gay, Daniel Ferraro, Simon A. Brown, Albert J. Chang, Peter J. Rossi, Benjamin W. Fischer-Valuck
Publikováno v:
Brachytherapy. 22:310-316
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10e529c592d79a83d8ff36604cd4a7c2
https://doi.org/10.1016/j.brachy.2022.12.004
https://doi.org/10.1016/j.brachy.2022.12.004
Autor:
Neal Andruska, Temitope Agabalogun, Benjamin W. Fischer-Valuck, Randall J. Brenneman, Yi Huang, Hiram A. Gay, Jeff M. Michalski, Ruben Carmona, Brian C. Baumann
Publikováno v:
Brachytherapy. 21:617-625
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32650bc646e96c145cc3609793eaf6d5
https://doi.org/10.1016/j.brachy.2022.04.001
https://doi.org/10.1016/j.brachy.2022.04.001
Autor:
Jacob Hogan, Amit Roy, Patricia Karraker, Jordan R. Pollock, Zachary Griffin, Neha Vapiwala, Jeffrey D. Bradley, Carlos A. Perez, Benjamin W. Fischer-Valuck, John C. Baumann, Brian C. Baumann
Publikováno v:
Int J Radiat Oncol Biol Phys
Radiation oncology (RO) has seen declines in Medicare reimbursement (MCR). However, there are no recent studies analyzing the contributions of specific billing codes to overall RO reimbursement. We compared total MCR for specific Healthcare Common Pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1766f1d4dfff8350db1131540fc51294
https://doi.org/10.1016/j.ijrobp.2022.05.018
https://doi.org/10.1016/j.ijrobp.2022.05.018